Hepatitis C viral quasispecies

Journal of Viral Hepatitis

Volumn 6, Issue 1, 1999, Pages 3-16

  Gomez J ^a   Martell, M ^a   Quer, J ^a   Cabot, B ^a   Esteban, J I ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Evolution; HCV; Quasispecies; Variability

Indexed keywords

COMPLEMENTARY DNA; INTERFERON; VIRUS RNA;

GENE MUTATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; SPECIES DIFFERENTIATION; VIRUS GENOME; VIRUS HEPATITIS; VIRUS INFECTION;

HEPACIVIRUS; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; LIVER; VARIATION (GENETICS);

EID: 0033056992     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1999.t01-1-6120131.x     Document Type: Review

References (115)

1. Eigen M. Self organization of matter and the evolution of biological macromolecules. Naturwissenschaften 1971; 58: 465-523.
2. Eigen M, Biebricher CK. Variability of RNA genomes: sequence space and quasispecies distribution. In: Domingo E, Holland JJ, Ahlquist P, eds. RNA Genetics 3. Vol. III. Florida: CRC Press, Inc., Boca Ratón, 1988: 211-245.
3. Nowak M, Schuster P. Error thresholds of replication in finite populations mutation frequencies and the onset of Muller's ratchet. J Theor Biol 1989; 137: 375-395.
4. Eigen M, McCaskill J, Schuster P. The molecular quasispecies. In: Prigogine I, Rice SS, eds. Advances in Chemical Physics. Vol. LXXV. New York: Wiley, 1989: 149-263.
5. Eigen M, Gardiner W, Schuster P, Winkler-Oswatitsch R. The origin of genetic information. Sci Am 1981; 244: 78-96.
6. Domingo E, Sabo D, Taniguchi T, Weissmann C. Phage population. Cell 1978; 13: 735-744.
7. Holland JJ. Spindler K, Horodyski F, Grabau E, Nichol S, VandePol S. Rapid evolution of RNA genomes. Science 1992; 215: 1577-1585.
8. Holland JJ, De La Torre JC, Steinhauer DA. RNA virus populations as quasispecies. Curr Top Microbiol Immunol 1992; 176: 1-20.
9. Domingo E, Holland JJ. RNA virus mutations and fitness for survival. Annu Rev Microbiol 1997; 51: 151-178.
10. Steinhauer DA, Holland JJ. Rapid evolution of RNA viruses. Annu Rev Microbiol 1987; 41: 409-433.
11. Quer J, Huerta R, Novella I, Tsimring L, Domingo E, Holland JJ. Reproducible nonlinear population dynamics and critical points during replicative competitions of RNA virus quasispecies. J Mol Biol 1996; 264: 465-471.
12. Domingo E, Holland JJ. Mutation rates and rapid evolution of RNA viruses. In: Morse SS, ed. Evolutionary Biology of Viruses. New York: Raven Press, 1994: 161-184.
13. Domingo E. RNA virus evolution and the control of viral disease. In: Jucker E, ed. Progress in Drug Research. 33. Vol. XXXIII. Basel: Birkhausee verlag. 1989: 93-133.
14. Domingo E, Martinez-Salas E, Sobrino F et al. The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance - a review. Gene 1985; 40: 1-8.
15. Domingo E. Biological significance of viral quasispecies. In: Di Bisceglíe M, ed. Viral Hepatitis Review. 2. London: W.B. Saunders Co., 1996: 247-261.
16. Holland JJ, De La Torre JC, Clarke DK, Duarte E. Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses. J Virol 1991; 65: 2960-2967.
17. Lewin B, Genes V. New York: Oxford University Press Inc., 1994.
18. Meyerhans A, Cheynier R, Albert J et al. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 1989; 58: 901-910.
19. Martell M, Esteban JI, Quer J et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1922; 66: 3225-3229.
20. Naito M, Hayashi N, Moribe T et al. Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes and patients with type C chronic liver disease. Hepatology 1995; 22: 407-412.
21. Esteban JI, Gómez J, Martell M et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996; 334: 555-560.
22. Maggi F, Fornai C, Vatteroni ML et al. Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma. J Gen Virol 1997; 78: 1521-1525.
23. Martell M, Esteban JI, Quer J et al. Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation. J Virol 1994; 68: 3425-3436.
24. Cabot B, Esteban JI, Martell M et al. Structure of replicating hepatitis C virus (HCV) quasispecies in the liver may be reflected by analysis of circulating HCV virions. J Virol 1997; 71: 1732-1734.
25. Koizumi K, Enomoto M, Kurosaki M et al. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 1995; 22: 30-35.
26. Honda M, Kaneko S, Sakai A, Unoura M, Murakami S, Kobayashi K. Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology 1994; 20: 1144-1151.
27. Kurosaki M, Enomoto N, Marumo F, Sato C. Variations in the core region of hepatitis C virus genomes in patients with chronic hepatitis. Arch Virol 1995; 140: 1087-1094.
28. Yuki N, Hayashi N, Moribe T et al. Relation of disease activity during chronic hepatitis C infection to complexity of hypervariable region 1 quasispecies. Hepatology 1997; 25: 439-444.
29. Toyoda H, Fukuda Y, Koyama Y, Takamatsu J, Saito H, Hayakawa T. Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus. J Hepatol 1997; 26: 975-982.
30. Rossini A, Ravaggi A, Biasi L et al. Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitis. Hepatology 1997; 26: 1012-1017.
31. Domingo E, Escarmís C, Sevilla N et al. Basic concepts in RNA virus evolution. FASEB J 1996; 10: 1-6.
32. Martínez MA, Vartanian JP, Wain-Hobson S. Hypermutagenesis of RNA using human immunodeficiency virus type 1 reverse transcriptase and biased dNTP concentrations. Proc Natl Acad USA 1994; 91: 11787-11791.
33. Okamoto H, Kojima M, Okada S et al. Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology 1992; 190: 894-899.
34. Ogata N, Alter HJ, Miller RH, Purcell RH. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 3392-3396.
35. Rocha E, Cox NJ, Black RA, Harmon MW, Harrison CJ, Kendal AP. Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child. J Virol 1991; 65: 2340-2350.
36. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995; 15: 41-63.
37. Yamaguchi K, Tanaka E, Higashi K et al. Adaptation of hepatitis C virus for persistent infection in patients with acute hepatitis. Gastroenterology 1994; 106: 1344-1348.
38. Kao JH, Chen PJ, Lai MY, Wang TH, Chen DS. Quasispecies of hepatitis C virus and genetic drift of the hypervariable region in chronic type C hepatitis. J Infect Dis 1995; 17: 261-264.
39. Kurosaki M, Enomoto N, Marumo F, Chifumi S. Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection. Hepatology 1993; 18: 1293-1299.
40. Kumar U, Monjardino J, Thomas HC. Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. Gastroenterology 1994; 106: 1072-1075.
41. Booth JC, Kumar U, Webster D, Monjardino J, Thomas HC. Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients. Hepatology 1998; 27: 223-227.
42. Lawal Z, Petrik J, Wong VS, Alexander GJ, Allain JP. Hepatitis C virus genomic variability in untreated and immunosuppressed patients. Virology 1997; 228: 107-111.
43. Odeberg J, Yun Z, Sonnerborg A, Bjoro K, Uhlen M, Lundeberg J. Variation of hepatitis C virus hypervariable region 1 in immunocompromised patients. J Infect Dis 1997; 175: 938-943.
44. Toyoda H, Fukuda Y, Koyama Y et al. Nucleotide sequence diversity of hypervariable region 1 of hepatitis C virus in Japanese hemophiliacs with chronic hepatitis C and patients with chronic posttransfusion hepatitis C. Blood 1996; 88: 1488-1493.
45. Wang C, Sarnow P, Siddiqui A. A conserved helical element is essential for internal initiation of translation of hepatitis C virus RNA. J Virol 1994; 68: 7301-7307.
46. Honda M, Brown EA, Lemon SM. Stability of a stemloop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA. KNA 1996; 2: 955-968.
47. Wang C, Le SY, Ali N, Siddiqui A. An RNA pseudoknot is an essential structural element of the internal ribosome entry site located within the hepatitis C virus 5′ non-coding region. RNA 1995; 1: 526-537.
48. Brown EA, Zajac AJ, Lemon SM. In vitro characterization of an internal ribosomal entry site (IRES) present within the 5′ nontranslated region of hepatitis A virus RNA: comparison with the IRES of encephalomyocarditis virus. J Virol 1994; 68: 1066-1074.
49. Lu HH, Wimmer E. Poliovirus chimeras replicating under the translational control of genetic elements of hepatitis C virus reveal unusual properties of the internal ribosomal entry site of hepatitis C virus. Proc Natl Acad Sci USA 1996; 93: 1412-1417.
50. Lemon SM. Targeting the Achilles' heel of hepatitis C virus. Hepatology 1997; 25: 1035-1037.
51. Domingo E, Diez J, Martínez MA et al. New observations on antigenic diversification of RNA viruses. Antigenic variation is not dependent on immune selection [published erratum appears in J Gen Virol 1994 Apr; 75 (Pt 4): 949]. J Gen Virol 1993; 74: 2039-2045.
52. Weiner AJ, Brauer MJ, Rosenblatt J et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991; 180: 842-848.
53. Kato N, Ootsuyama Y, Sekiya H et al. Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J Virol 1994; 68: 4776-4784.
54. Kato N, Sekiya H, Ootsuyama Y et al. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 1993; 67: 3923-3930.
55. van Doom LJ, Capriles I, Maertens G et al. Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. J Virol 1995; 69: 773-778.
56. Weiner AJ, Geysen HM, Christopherson C et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA 1992; 89: 3468-3472.
57. Farci P, Alter HJ, Wong DC et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA 1994; 91: 7792-7796.
58. Kojima M, Osuga T, Tsuda F, Tanaka T, Okamoto H. Influence of antibodies to the hypervariable region of E2/NS1 glycoprotein on the selective replication of hepatitis C virus in chimpanzees. Virology 1994; 204: 665-672.
59. Sekiya H, Kato N, Ootsuyama Y, Nakazawa T, Yamauchi K, Shimotohno K. Genetic alterations of the putative envelope proteins encoding a region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: humoral immune response to hypervariable region 1. Int J Cancer 1994; 57: 664-670.
60. Weiner A, Erickson AL. Kansopon J et al. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci USA 1995; 92: 2755-2759.
61. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 1991; 14: 381-388.
62. Simmonds P. Variability of hepatitis C virus. Hepatology 1995; 21: 570-583.
63. Branch AD, Benenfeld BJ, Robertson HD. RNA fingerprinting. Methods Enzymol 1989; 180: 130-154.
64. Casacuberta JM, Vernhettes S, Grandbastien MA. Sequence variability within the tobacco retrotransposon Tnt1 population. EMBO J 1995; 14: 2670-2678.
65. Najera I, Holguin A, Quinones-Mateu ME et al. Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy. J Virol 1995; 69: 23-31.
66. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989; 86: 2766-2770.
67. Moribe T, Hayashi N, Kanazawa Y et al. Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy. Gastroenterology 1995; 108: 789-795.
68. Enomoto N, Kurosaki M, Tanaka Y, Marumo F, Sato C. Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis. J Gen Virol 1994; 75: 1361-1369.
69. Lu M, Funsch B, Wiese M, Roggendorf M. Analysis of hepatitis C virus quasispecies populations by temperature gradient gel electrophoresis. J Gen Virol 1995; 76: 881-887.
70. Wilson JJ, Polyak SJ, Day TD, Gretch DR. Characterization of simple and complex hepatitis C virus quasispecies by heteroduplex gel shift analysis: correlation with nucleotide sequencing. J Gen Virol 1995; 76: 1763-1771.
71. Polyak SJ, Faulkner G, Carithers RL Jr, Corey L, Gretch DR. Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: correlation with response to interferon therapy. J Infect Dis 1997; 175: 1101-1107.
72. Domingo E. RNA virus evolution, population dynamics, and nutritional status. Biol Trace Elem Res 1997; 56: 23-30.
73. Weiner AJ, Thaler MM, Crawford K et al. A unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants. J Virol 1993; 67: 4365-4368.
74. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. D-related human leukocyte antigens and disease severity in chronic hepatitis C. Hepatology 1995; 22 (suppl): 339A.
75. Esteban JI, Gómez J, Martell M, Guardi J. Hepatitis C. In: Wilson RA, ed. Vital hepatitis. New York: Marcel Dekker Inc., 1997: 147-216.
76. Ahmed R, Stevens JG. Viral persistence. In: Fields BN, Kniep DN, eds. Fundamental Virology. New York: Raven, 1991: 241-265.
77. Kirkwood TB, Bangham CR. Cycles, chaos, and evolution in virus cultures: a model of defective interfering particles. Proc Natl Acad Sci USA 1994; 91: 8685-8689.
78. Barrett AD, Dimmock NJ. Defective interfering viruses and infections of animals. Curr Top Microbiol Immunol 1986; 128: 55-84.
79. Higashi Y, Kakumu S, Yoshioka K et al. Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 1993; 197: 659-668.
80. Yoo BJ, Selby MJ, Choe J et al. Transfection of a differentiated human hepatoma cell line (Huh7) with in vitrotranscribed hepatitis C virus (HCV) RNA and establishment of a long-term culture persistently infected with HCV. J Virol 1995; 69: 32-38.
81. Shimizu YK, Yoshikura H. In vitro systems for the detection of hepatitis C virus infection. Viral Hep Rev 1995; 1: 59-65.
82. Martin Hernández AM, Carrillo EC, Sevilla N, Domingo E. Rapid cell variation can determine the establishment of a persistent viral infection. Proc Natl Acad Sci USA 1994; 91: 3705-3709.
83. Shirai M, Okada H, Nishioka M et al. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J Virol 1994; 68: 3334-3342.
84. Battegay M, Fikes J, Di Bisceglie AM et al. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol 1995; 69: 2462-2470.
85. Rehermann B, Chang KM, McHutchison JG, Chisari FV. Comparative analysis of the cytotoxic T cell response in chronic HBV and HCV infection. Hepatology 1995; 22 (suppl): 334A.
86. Ballardini G, Groff P, Pontisso P et al. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C. J Clin Invest 1995; 95: 2067-2075.
87. Nelson DR, Marousis CG, Davis GL, Lau JYN. Defining the role of intrahepatic HCV-specific cytotoxic T-lymphocytes in chronic hepatitis C. Hepatology 1995; 22 (suppl): 287A.
88. Yun Z, Barkholt L, Sonnerborg A. Dynamic analysis of hepatitis C virus polymorphism in patients with orthotopic liver transplantation. Transplantation 1997; 64: 170-172.
89. Gretch DR, Polyak SJ, Wilson JJ, Carithers RL Jr, Perkins JD, Corey L. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J Virol 1996; 70: 7622-7631.
90. Scarcelli E, Cerino A, Esposito C, Silini E, Mondelli MU, Traboni C. Occurrences of antibodies reactive with more than one variant of the putative envelope glycoprotein (Gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients. J Virol 1995; 69: 4407-4412.
91. Gerber MA. Pathobiologic effects of hepatitis C. J Hepatol 1995; 22 (suppl): 83-86.
92. Negro F, Pacchioni D, Shimizu Y et al. Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology. Proc Natl Acad Sci USA 1992; 89: 2247-2251.
93. Kato N, Hijikata M, Ootsuyama Y et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 1990; 87: 9524-9528.
94. Martin P, Di Bisceglie AM, Kassianides C, Lisker-Melman M, Hoofnagle JH. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology 1989; 97: 1559-1561.
95. Pol S, Trinh TN, Thiers V et al. Chronic hepatitis C of drug users: influence of HIV infection. Hepatology 1995: 22 (suppl): 340A.
96. Bjoro K, Froland SS, Yun Z, Samdal HH, Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 1994; 331: 1607-1611.
97. Hayashi J, Kishihara Y, Yamaji K et al. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection. Hepatology 1997; 25: 697-701.
98. González-Peralta RP, Davis GL, Lau JY. Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection. J Hepatol 1994; 21: 255-259.
99. Sakamoto N, Enomoto N, Kurosaki M et al. Comparison of the hypervariable region of hepatitis C virus genomes in plasma and liver. J Med Virol 1995; 46: 7-11.
100. Wong JK, Ignacio CC, Torriani F, Havlir D, Fitch NJ, Richman DD. In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues. J Virol 1997; 71: 2059-2071.
101. Horie C, Iwahana H, Horie T et al. Detection of different quasispecies of hepatitis C virus core region in cancerous and noncancerous lesions. Biochem Biophys Res Commun 1996; 218: 674-681.
102. Shimizu YK, Igarashi H, Kanematu T et al. Sequence analysis of the hepatitis C virus genome recovered from serum, liver, and peripheral blood mononuclear cells of infected chimpanzees. J Virol 1997; 71: 5769-5773.
103. Kanazawa Y, Hayashi N, Mita E et al. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients. Hepatology 1994; 20: 1121-1130.
104. Le Guen B, Squadrito G, Nalpas B, Berthelot P, Pol S, Brechot C. Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C. Hepatology 1997; 25: 1250-1254.
105. Shindo M, Hamada K, Koya S, Arai K, Sokawa Y, Okuno T. The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy. Hepatology 1996; 24: 1018-1023.
106. Hagiwara H, Hayashi N, Kasahara A et al. Treatment with recombinant interferon-alpha 2a for patients with chronic hepatitis C: predictive factors for biochemical and virologic response. Scand J Gastroenterol 1996; 31: 1021-1026.
107. Toyoda H, Kumada T, Nakano S et al. Quasispecies nature of hepatitis C virus and response to alpha interferon: significance as a predictor of direct response to interferon. J Hepatol 1997; 26: 6-13.
108. Sakuma I, Enomoto N, Kurosaki M, Marumo F, Sato C. Selection of hepatitis C virus quasispecies during interferon treatment. Arch Virol 1996; 141: 1921-1932.
109. Gonzalez-Peralta RP, Liu WZ, Davis GL, Qian KP, Lau JY. Modulation of hepatitis C virus quasispecies heterogeneity by interferon-alpha and ribavirin therapy. J Viral Hep 1997; 4: 99-106.
110. Yun ZB, Odebcrg J, Lundeberg J, Weiland O, Uhlen M, Sonnerborg A. Restriction of hepatitis C virus heterogeneity during prolonged interferon-alpha therapy in relation to changes in virus load. J Infect Dis 1996; 173: 992-996.
111. Enomoto N, Sakuma I, Asahina Y et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 1995; 96: 224-230.
112. Enomoto E, Sakuma I, Asahina Y et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996; 334: 77-81.
113. Herion D, Hoofnagle JH. The interferon sensitivity determining region: all hepatitis C virus isolates are not the same. Hepatology 1997; 25: 769-771.
114. Squadrito G, Leone F, Sartori M et al. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa. Gastroenterology 1997; 113: 567-572.
115. Sáiz JC, López-Labrador FX, Ampurdanés S et al. The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus. J Infect Dis 1998; 177: 839-847.